Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant’s bivalent Covid booster.
Vaccine advisors who signed off on the updated shot late last year claim they were not shown trial data that indicated the booster was actually less effective at preventing Covid than the older vaccine it was meant to replace.
While the early trial results had substantial limitations, ‘disappointed’ and ‘angry advisors say its omission from panel discussions shows a remarkable lack of transparency.
New documents published by the Department of Health and Social Care show that Doja Limited were awarded the multi-million pound contract in May of last year. The company’s director has said it was founded to sell “rare diamonds”, and does not appear to have a history of supplying PPE.
The company, which has no website and is registered to an accountant’s firm, was handed the contract under a controversial scheme which allows ministers to directly award deals relating to procurement during the pandemic without putting the tender to a competitive process.